R. Centenaro

Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study.

S. Lazzaroni, E. Buscarini, P. Lampertico, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C.

S. Lazzaroni, P. Lampertico, A. Gori, 2019, Journal of hepatology.

Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort

A. d’Arminio Monforte, S. Lazzaroni, M. Valsecchi, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Iodide mumps: Sonographic appearance

G. Lavecchia, R. Centenaro, S. Greco, 2010, Journal of clinical ultrasound : JCU.

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure.

A. Alberti, P. Lampertico, P. Pozzoni, 2019, Journal of hepatology.

Reprocessing in digestive endoscopy units in Lombardy: results of a regional survey.

G. Spinzi, R. Fasoli, G. Minoli, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Real-life effectiveness and safety of Glecaprevir/Pibrentasvir among 723 Italian patients with chronic hepatitis C: The Navigator-II study

S. Lazzaroni, E. Buscarini, G. Spinzi, 2018 .

Real-life effectiveness and safety of Glecaprevir/Pibrentasvir among 723 Italian patients with chronic hepatitis C: The Navigator-II study

S. Lazzaroni, E. Buscarini, G. Spinzi, 2018 .

574 Prolonged N-3 PUFA dietary supplementation improves fatty liver in patients with NAFLD

A. Mugelli, S. Milani, A. Casini, 2004 .